JP2016520193A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520193A5
JP2016520193A5 JP2016514046A JP2016514046A JP2016520193A5 JP 2016520193 A5 JP2016520193 A5 JP 2016520193A5 JP 2016514046 A JP2016514046 A JP 2016514046A JP 2016514046 A JP2016514046 A JP 2016514046A JP 2016520193 A5 JP2016520193 A5 JP 2016520193A5
Authority
JP
Japan
Prior art keywords
stimulating hormone
hormone receptor
motomeko
thyroid
chelating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016514046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520193A (ja
JP6472789B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037909 external-priority patent/WO2014186402A1/en
Publication of JP2016520193A publication Critical patent/JP2016520193A/ja
Publication of JP2016520193A5 publication Critical patent/JP2016520193A5/ja
Application granted granted Critical
Publication of JP6472789B2 publication Critical patent/JP6472789B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016514046A 2013-05-14 2014-05-13 受容体含有安定化液剤 Active JP6472789B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361823116P 2013-05-14 2013-05-14
US61/823,116 2013-05-14
PCT/US2014/037909 WO2014186402A1 (en) 2013-05-14 2014-05-13 Stabilized liquid formulations containing receptors

Publications (3)

Publication Number Publication Date
JP2016520193A JP2016520193A (ja) 2016-07-11
JP2016520193A5 true JP2016520193A5 (https=) 2017-06-22
JP6472789B2 JP6472789B2 (ja) 2019-02-20

Family

ID=51898832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514046A Active JP6472789B2 (ja) 2013-05-14 2014-05-13 受容体含有安定化液剤

Country Status (6)

Country Link
US (2) US10203338B2 (https=)
EP (1) EP2997039B1 (https=)
JP (1) JP6472789B2 (https=)
CN (1) CN105209486B (https=)
ES (1) ES2747634T3 (https=)
WO (1) WO2014186402A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119492871A (zh) * 2018-09-26 2025-02-21 北卡罗来纳-查佩尔山大学 用于改进测定的化合物、组合物和方法
JP7269906B2 (ja) * 2019-10-29 2023-05-09 三洋化成工業株式会社 免疫測定用試薬、免疫測定用キット及び免疫測定方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen
US4711856A (en) * 1984-09-19 1987-12-08 Mayo Medical Resources Nuclear binding assay for steroid receptor functionality in cancerous cells
US5089390A (en) 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5185243A (en) 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
US5508178A (en) 1989-01-19 1996-04-16 Rose; Samuel Nucleic acid amplification using single primer
US5340716A (en) 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US6100071A (en) * 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
ATE510552T1 (de) * 1996-06-05 2011-06-15 Basil Rapoport Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
US20030099608A1 (en) * 2001-03-27 2003-05-29 Presnell Scott R. Human cytokine receptor
JP4744147B2 (ja) * 2002-11-26 2011-08-10 ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー アフィニティー精製抗体を用いた甲状腺刺激ホルモン受容体自己抗体の同定
JP5405111B2 (ja) * 2005-09-26 2014-02-05 ウルリヒ ルース Ｔｓｈ受容体及び新規ｔｓｈ受容体キメラに対する自己免疫抗体検出方法
US20080305098A1 (en) * 2005-11-21 2008-12-11 Dr. Fenning Biomed Gmbh Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
JP5832723B2 (ja) * 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−２受容体定量用標準品
JP2011136911A (ja) * 2009-12-25 2011-07-14 Tosoh Corp 甲状腺刺激ホルモンレセプターの安定化方法

Similar Documents

Publication Publication Date Title
RU2018127537A (ru) Соединения и способы лечения phk-опосредованных заболеваний
CN103787879B (zh) 一种王浆酸衍生物及其制备方法和应用
JP2013537874A5 (https=)
JP2019513770A5 (https=)
JP2010522791A5 (https=)
JP2011173892A5 (https=)
JP2018506575A5 (https=)
JP2015534601A5 (https=)
JP2001522828A5 (https=)
BRPI0507746A (pt) composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
JP2014149886A5 (https=)
AR105044A1 (es) Soluciones de esteroides neuroactivos y sus métodos de uso, recipiente
AR086871A1 (es) Composicion descongelante, proceso de preparacion, conjunto de partes y uso
JP2015091877A5 (https=)
CL2019002678A1 (es) Composición adhesiva y método para preparar la misma.
JP2012162465A5 (https=)
JP2016520193A5 (https=)
JP2017526747A5 (https=)
CN103342769A (zh) 一种钼分离树脂的制备方法
JP2017516808A5 (https=)
JP2012528801A5 (https=)
CN104886072A (zh) 一种戊唑醇水乳剂
JP2012025749A5 (https=)
GB331459A (https=)
RU2008105229A (ru) Нитроксисукцинат 2-этил-6-метил-3-оксипиридина и способ его получения